IBTROZI vs SIROLIMUS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. IBTROZI and SIROLIMUS are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	IBTROZI	SIROLIMUS
Rating	New	66/100
Pharmacy pays	—	~$48.61 /30
Type	RX	RX
Active ingredient	TALETRECTINIB ADIPATE	SIROLIMUS
Manufacturer	Nuvation	Apotex
Dosage forms	Capsule	Solution
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	Boxed warning
Treats	Non-Small-Cell Lung Carcinoma	Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

ibtrozi sirolimus

Rating

New

66/100

Pharmacy pays

—

~$48.61 /30

Type

Active ingredient

TALETRECTINIB ADIPATE

SIROLIMUS

Manufacturer

Nuvation

Apotex

Dosage forms

Capsule

Solution

Drug class

Kinase Inhibitor

Boxed warning

None

Boxed warning

Treats

Non-Small-Cell Lung Carcinoma

Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

Frequently asked questions

What is the difference between Ibtrozi and Sirolimus?

Ibtrozi contains Taletrectinib Adipate, while Sirolimus contains Sirolimus — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.